Leesol Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
Series A2
- Latest Deal Amount
-
$2.07M
- Investors
-
11
Leesol General Information
Description
Developer of an Artificial Intelligence based neuromodulation technology designed to provide prevention and treatment for healthy brains. The company creates devices for improving sleep disorders and preventing dementia using Transcranial Alternating Current Stimulation (tACS) type cranial electrical stimulation, enabling patients with sleep disorders to enhance sleep quality, reduce stress, and support mental balance.
Contact Information
Website
www.leesolbrain.comCorporate Office
- 24th floor, 7-8, Jungang-daero 214beongil
- Dong-gu, Choryang-dong, Asti Hotel Busan
- Busan
- South Korea
Corporate Office
- 24th floor, 7-8, Jungang-daero 214beongil
- Dong-gu, Choryang-dong, Asti Hotel Busan
- Busan
- South Korea
Leesol Timeline
Leesol Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series A2) | 19-Feb-2026 | $2.07M | Completed | Generating Revenue | ||
| 5. Later Stage VC (Series A) | 02-Oct-2024 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 3. Accelerator/Incubator | 31-Aug-2023 | Completed | Generating Revenue | |||
| 2. Seed Round | 18-May-2023 | Completed | Generating Revenue | |||
| 1. Product Crowdfunding | 08-Apr-2023 | $5.91K | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Leesol Patents
Leesol Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260263735-A1 | Method, device, and system for stimulating brain network | Pending | 10-Mar-2025 | ||
| JP-2026149456-A | Methods, devices, and systems for stimulating brain networks | Pending | 10-Mar-2025 | ||
| JP-2026116780-A | Method for providing biofeedback for personalized management, and user terminal and control method thereof. | Pending | 31-Dec-2024 | ||
| US-20260183507-A1 | Method for providing biofeedback for personalized management, user terminal, and method of controlling the user terminal | Pending | 31-Dec-2024 | ||
| JP-2025105405-A | Personalized brain stimulation device | Active | 28-Dec-2023 | A61N1/36031 |
Leesol Signals
Leesol Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BNK Venture Capital | Venture Capital | Minority | ||
| NAU IB Capital | PE/Buyout | Minority | ||
| Soo Investment Capital | Venture Capital | Minority | ||
| Spacetime Investment | Corporate Venture Capital | Minority | ||
| Alternative Investment Management | Family Office | Minority |
Leesol FAQs
-
When was Leesol founded?
Leesol was founded in 2017.
-
Where is Leesol headquartered?
Leesol is headquartered in Busan, South Korea.
-
What is the size of Leesol?
Leesol has 12 total employees.
-
What industry is Leesol in?
Leesol’s primary industry is Therapeutic Devices.
-
Is Leesol a private or public company?
Leesol is a Private company.
-
What is Leesol’s current revenue?
The current revenue for Leesol is .
-
How much funding has Leesol raised over time?
Leesol has raised $5.07M.
-
Who are Leesol’s investors?
BNK Venture Capital, NAU IB Capital, Soo Investment Capital, Spacetime Investment, and Alternative Investment Management are 5 of 11 investors who have invested in Leesol.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process